Prescription drug insurance coverage and patient health outcomes: A systematic review

American Journal of Public Health

Volumn 105, Issue 2, 2015, Pages e17-e30

  Kesselheim, Aaron S ^a   Huybrechts, Krista F ^a   Choudhry, Niteesh K ^a   Fulchino, Lisa A ^a   Isaman, Danielle L ^a   Kowal, Mary K ^a   Brennan, Troyen A ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CVS Caremark   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ECONOMICS; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; INSURANCE; OUTCOME ASSESSMENT; STATISTICS AND NUMERICAL DATA; UNITED STATES;

HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; PATIENT OUTCOME ASSESSMENT; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PRESCRIPTION DRUGS; UNITED STATES;

EID: 84921844069     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.302240     Document Type: Review

References (49)

1. Council of Economic Advisers. The economic case for health care reform. Available at: http: //www. whitehouse. gov/ assets/documents/CEA-Health-Care- Report. pdf. Accessed October 6, 2014.
2. United States Senate. Strengthening Medicare for today and the future. Available at: http: //www. aging. senate. gov/hearings/ strengthening-medicare-for-today-and-thefuture. Accessed October 6, 2014.
3. Thomas K. US drug costs dropped in 2012, but rises loom. Available at: http: // www. nytimes. com/2013/03/19/business/ use-of-generics-produces-an-unusual-dropin-drug-spending. html?pagewanted=all&- r=0. Accessed October 6, 2014.
4. Kaiser Family Foundation. Medicaid payment for outpatient prescription drugs. Available at: http: //www. kff. org/ medicaid/upload/1609-04. pdf. Accessed October 6, 2014.
5. Galewitz P. States cut Medicaid drug benefits to save money. Available at: http: //www. kaiserhealthnews. org/ Stories/2012/July/25/medicaid-cutssidebar. aspx. Accessed October 6, 2014.
6. Hoadley JF, Merrell K, Hargrave E, Summer L. In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions. Health Aff (Millwood). 2012; 31(10): 2266-2275.
7. Lingle EW Jr, Kirk KW, Kelly WR. The impact of outpatient drug benefits on the use and costs of health care services for the elderly. Inquiry. 1987; 24(3): 203-211.
8. Stuart B, Doshi JA, Briesacher B, Wrobel MV, Baysac F. Impact of prescription coverage on hospital and physician costs: a case study of Medicare beneficiaries with chronic obstructive pulmonary disease. Clin Ther. 2004; 26(10): 1688-1699.
9. Dale SB, Verdier JM. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage. Available at: http: //www. commonwealthfund. org/; /media/files/publications/issuebrief/ 2003/apr/state-medicaidprescription-drug-expenditures-formedicare-medicaid-dual-eligibles/ dale-rxdualeligibles-ib-627-pdf. pdf. Accessed October 6, 2014.
10. Briesacher BA, Stuart B, Ren X, Doshi JA, Wrobel MV. Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending. Health Serv Res. 2005; 40(5): 1279-1296.
11. Gilman BH, Gage B, Haber S, Hoover S, Aggarwal J. Impact of drug coverage on medical expenditures among the elderly. Health Care Financ Rev. 2007; 29(1): 103-118.
12. Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011; 365(22): 2088-2097.
13. Lee JL, Maciejewski M, Raju S, Shrank WH, Choudhry NK. Value-based insurance design: quality improvement but no cost savings. Health Aff (Millwood). 2013; 32(7): 1251-1257.
14. Federman AD, Adams AS, Ross-Degnan D, Soumerai SB, Ayanian JZ. Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease. JAMA. 2001; 286(14): 1732-1739.
15. Polinski JM, Donohue JM, Kilabuk E, Shrank WH. Medicare Part D's effect on the under-and overuse of medications: a systematic review. J Am Geriatr Soc. 2011; 59(10): 1922-1933.
16. Yin W, Basu A, Zhang JX, Rabbani A, Meltzer DO, Alexander GC. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med. 2008; 148(3): 169-177.
17. Donohue JM, Zhang Y, Aiju M, et al. Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression. Am J Geriatr Psychiatry. 2011; 19(12): 989-997.
18. Lu CY, Adams AS, Ross-Degnan D, et al. Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder. Psychiatr Serv. 2011; 62(2): 186-193.
19. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Available at: http: //www. cochranehandbook. org. Accessed October 6, 2014.
20. Khan N, Kaestner R, Lin SJ. Effect of prescription drug coverage on health of the elderly. Health Serv Res. 2008; 43(5): 1576-1597.
21. Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003; 22(4): 220-229.
22. Bhattacharya J, Goldman D, Sood N. The link between public and private insurance and HIV-related mortality. J Health Econ. 2003; 22(6): 1105-1122.
23. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, costrelated medication underuse, and outcomes among diabetes patients in 3 systems of care. Med Care. 2004; 42(2): 102-109.
24. Bleich SN, Cutler DM, Adams AS, Lozano R, Murray CJ. Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. BMJ. 2007; 335(7625): 875.
25. Boyle RG, Solberg LI, Magnan S, Davidson G, Alesci NL. Does insurance coverage for drug therapy affect smoking cessation. Health Aff (Millwood). 2002; 21(6): 162-168.
26. Afendulis CC, He Y, Zaslavsky AM, Chernew ME. The impact of Medicare Part D on hospitalization rates. Health Serv Res. 2011; 46(4): 1022-1038.
27. Donohue JM, Marcum ZA, Gellad WF, Lave JR, Men A, Hanlon JT. Medicare Part D and potentially inappropriate medication use in the elderly. Am J Manag Care. 2012; 18(9): e315-e322.
28. Liu FX, Alexander GC, Crawford SY, Pickard AS, Hedeker D, Walton SM. The impact of Medicare Part D on out-ofpocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility. Health Serv Res. 2011; 46(4): 1104-1123.
29. Kozma CM, Reeder CE, Lingle EW. Expanding Medicaid drug formulary coverage. Med Care. 1990; 28(10): 963-977.
30. Balkrishnan R, Byerly WG, Camacho FT, Shrestha A, Anderson RT. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population. Am J Manag Care. 2001; 7(11): 1093-1100.
31. Shaw T, Carrozza M. Is access sufficient. An examination of the effects of theMedShare program to expand access to prescription drugs for indigent populations. Eval Rev. 2008; 32(6): 526-546.
32. Spiker EC, Giannamore MR, Nahata MC. Medication use patterns and health outcomes among patients using a subsidized prescription drug program. J Am Pharm Assoc. 2005; 45(6): 714-719.
33. Chisholm MA, Spivey CA, Mulloy LL. Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients. Am J Health Syst Pharm. 2007; 64(14): 1506-1512.
34. Fuller BE, Rieckmann TR, McCarty DJ, Ringor-Carty R, Kennard S. Elimination of methadone benefits in the Oregon Health Plan and its effects on patients. Psychiatr Serv. 2006; 57(5): 686-691.
35. Raebel MA, Delate T, Ellis JL, Bayliss EA. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D. Med Care. 2008; 46(10): 1116-1122.
36. Fung V, Price M, Busch AB, et al. Adverse clinical events among Medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs. Med Care. 2013; 51(7): 614-621.
37. Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Roebuck MC, Schneeweiss S. Beneficiaries with cardiovascular disease and the Part D coverage gap. Circ Cardiovasc Qual Outcomes. 2012; 5 (3): 387-395.
38. Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Christopher Roebuck M, Schneeweiss S. Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc. 2012; 60 (8): 1408-1417.
39. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006; 354(22): 2349-2359.
40. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin TJ, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991; 325(15): 1072-1077.
41. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994; 331(10): 650-655.
42. Gottlieb S. Medicaid is worse than no coverage at all. Available at: http: //online. wsj. com/articles/SB10001424052748-704758904576188280858303612. Accessed October 6, 2014.
43. Associated Press. Heineman says Nebraska Medicaid bill "should not pass. " Available at: http: //www. wowt. com/ news/headlines/Heineman-Says-Nebraska-Medicaid-Bill-Should-Not-Pass-203045321. html. Accessed October 6, 2104.
44. Congressional Budget Office. Estimates for the insurance coverage provisions of the Affordable Care Act updated for the recent Supreme Court decision. July 2012. Available at: http: //www. cbo. gov/sites/default/files/cbofiles/attachments/ 43472-07-24-2012-CoverageEstimates. pdf. Accessed October 6, 2104.
45. DeLeire T, Dague L, Leininger L, Voskuil K, Friedsam D. Wisconsin experience indicates that expanding public insurance to low-income childless adults has health care impacts. Health Aff (Millwood). 2013; 32(6): 1037-1045.
46. Sommers BD, Baicker K, Epstein AM. Mortality and access to care among adults after state Medicaid expansions. N Engl J Med. 2012; 367(11): 1025-1034.
47. Finkelstein A, Taubman S, Wright B, et al. The Oregon health insurance experiment: evidence from the first year. Q J Econ. 2012; 127(3): 1057-1106.
48. Baicker K, Taubman SL, Allen HL, et al. The Oregon experiment-effects of Medicaid on clinical outcomes. N Engl J Med. 2013; 368(18): 1713-1722.
49. Khan N, Kaestner R. Effect of prescription drug coverage on the elderly's use of prescription drugs. Inquiry. 2009; 46(1): 33-45